Tgf-Stimulates Expression Of Chondroitin Polymerizing Factor In Nucleus Pulposus Cells Through The Smad3, Rhoa/Rock1, And Mapk Signaling Pathways

Bo Hu,Chen Xu,Peng Cao,Ye Tian,Ying Zhang,Changgui Shi,Jun Xu,Wen Yuan,Huajiang Chen
DOI: https://doi.org/10.1002/jcb.26215
2018-01-01
Journal of Cellular Biochemistry
Abstract:The enzyme chondroitin polymerizing factor (ChPF) is primarily involved in extension of the chondroitin sulfate backbone required for the synthesis of sulfated glycosaminoglycan (sGAG). Transforming growth factor beta (TGF-) upregulates sGAG synthesis in nucleus pulposus cells; however, the mechanisms mediating this induction are incompletely understood. Our study demonstrated that ChPF expression was negatively correlated with the grade of degenerative intervertebral disc disease. Treatment of nucleus pulposus cells with TGF- induced ChPF expression and enhanced Smad2/3, RhoA/ROCK activation, and the JNK, p38, and ERK1/2 MAPK signaling pathways. Selective inhibitors of Smad2/3, RhoA or ROCK1/2, and knockdown of Smad3 and ROCK1 attenuated ChPF expression and sGAG synthesis induced by TGF-. In addition, we showed that RhoA/ROCK1 signaling upregulated ChPF via activation of the JNK pathway but not the p38 and ERK1/2 signaling pathways. Moreover, inhibitors of JNK, p38 and ERK1/2 activity also blocked ChPF expression and sGAG synthesis induced by TGF- in a Smad3-independent manner. Collectively, our data suggest that TGF- stimulated the expression of ChPF and sGAG synthesis in nucleus pulposus cells through Smad3, RhoA/ROCK1 and the three MAPK signaling pathways. J. Cell. Biochem. 119: 566-579, 2018. (c) 2017 Wiley Periodicals, Inc.
What problem does this paper attempt to address?